Author

Danielle E. Baranova

Pfizer (United States)ORCID 0000-0003-2318-428XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1 Approach:experimental assay· 1 Assay:proteomics· 1

Frequent Co-Authors

Annalena La Porte· 1 shared Arthur Illenberger· 1 shared Cara Kobylarz· 1 shared Christopher Ponce· 1 shared Elizabeth KepliD· 1 shared Jacqueline Lypowy· 1 shared L Liu· 1 shared Laurent Chorro· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Annalena La Porte

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologyFrontiers in ImmunologyPeer-reviewedJul 21, 2026

Improving the immunogenicity of E. coli FimH via multivalent display on I53-50 nanoparticles

Rebecca S Cole, Natalie C. Silmon de Monerri, Jacqueline Lypowy…·Neil P. King

This paper improves the immunogenicity of E. coli FimH by displaying it on I53-50 nanoparticles, achieving comparable antibody responses to higher doses of monomeric FimH with reduced adjuvant needs.

2 citations

E. coliproteomics

𝕏 PostBluesky